Search for: "Lisa Ouellette"
Results 1 - 20
of 173
Sort by Relevance
|
Sort by Date
23 Jan 2024, 11:32 am
A pre-ChatGPT paper co-authored by Sharon Sandeen questions whether AI related information like algorithms and training data qualifies for trade secrecy.On patentability of AI, I found this Stanford Law panel from 2019 featuring Lisa Ouellette and Mark Lemley very informative and not outdated. [read post]
10 Jan 2024, 10:50 am
On a recent episode of the Stanford Law School podcast, Stanford Legal, Lisa Larrimore Ouellette, the Deane F. [read post]
2 Aug 2023, 2:00 am
Lisa Larrimore Ouellette (Stanford University), IP and Public Research in Health Emergencies: U.S. [read post]
4 Apr 2023, 3:30 am
Lisa Larrimore Ouellette Inequality among innovators is a substantial social problem in terms of both equity and economic growth. [read post]
26 Feb 2023, 8:00 pm
Masur (Chicago Law) and Lisa Larrimore Ouellette (Stanford Law). [read post]
22 Jul 2022, 2:00 am
Lisa Larrimore Ouellette (Stanford University), W. [read post]
8 Jun 2022, 5:23 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
3 Mar 2022, 6:43 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsSince the pandemic began, numerous recovered COVID-19 patients have reported having “long COVID”: COVID-19 symptoms persisting well beyond the underlying viral infection period. [read post]
17 Feb 2022, 3:30 am
Lisa Larrimore Ouellette Patent and copyright law share what the Supreme Court calls a “historic kinship”: they both grant exclusive rights under the IP Clause to incentivize production of new knowledge goods. [read post]
1 Feb 2022, 6:48 am
Durvasula, Lisa Larrimore Ouellette, and Heidi L. [read post]
21 Jan 2022, 8:35 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe FDA has now authorized three vaccines and several treatments (including both monoclonal antibodies and small-molecule drugs) for the prevention and treatment of COVID-19. [read post]
1 Dec 2021, 2:00 am
Lisa Larrimore Ouellette (Stanford Law School), Michael Abramowicz (George Washington University), Daniel J. [read post]
5 Nov 2021, 8:20 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
1 Nov 2021, 11:53 am
Masur & Lisa Larrimore Ouellette, Patent Law: Cases, Problems and Materials (2021) Craig A. [read post]
12 Oct 2021, 2:00 am
Rachel Sachs (Washington University in Saint Louis) Lisa Larrimore Ouellette (Stanford University) W. [read post]
27 Sep 2021, 7:26 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsHistorically, the United States’ preparedness for a pandemic is like Charles Dudley Warner’s aphorism on the weather: everybody talks about it but no one ever does anything. [read post]
27 Aug 2021, 12:18 pm
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn previous blog posts in this series, we have explored the roles different federal agencies, including the NIH, FDA, and CMS, play in the development and distribution of new healthcare technologies in the fight against COVID-19. [read post]
30 Jun 2021, 10:31 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
3 Jun 2021, 8:56 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsRecently, Pfizer and BioNTech and Moderna announced that they are seeking full FDA approval for their mRNA COVID-19 vaccines—filing, in FDA parlance, a Biologics License Application (BLA). [read post]
4 May 2021, 7:42 am
Lisa Larrimore Ouellette is a Professor of Law and Justin M. [read post]
